Skip to main navigation Skip to search Skip to main content

Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates

David M. McDonald, Brendan L. Wilkinson, Leo Corcilius, Morten Thaysen-Andersen, Scott N. Byrne, Richard J. Payne*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    Abstract

    We describe herein the synthesis and immunological evaluation of self-adjuvanting mucin 1 (MUC1)-macrophage activating lipopeptide 2 (MALP2) (glyco)peptide vaccine candidates. Vaccine constructs were shown to induce high titres of class-switched IgG antibodies in C57BL/6 mice after four immunisations despite the lack of a helper T cell epitope. This journal is

    Original languageEnglish
    Pages (from-to)10273-10276
    Number of pages4
    JournalChemical Communications
    Volume50
    Issue number71
    DOIs
    Publication statusPublished - 14 Sept 2014

    Fingerprint

    Dive into the research topics of 'Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates'. Together they form a unique fingerprint.

    Cite this